Tournay Biotechnologies Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Tournay Biotechnologies General Information

Description

Produces natural ingredients for the health and food industry. The company extracts active botanicals and produces natural ingredients for the nutraceutical and dietary supplements industries.

Contact Information

Website
www.tournay.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Zae Le Noyer Brule
  • 24230 Lamothe Montravel
  • France
Primary Industry
Other Chemicals and Gases
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Zae Le Noyer Brule
  • 24230 Lamothe Montravel
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tournay Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tournay Biotechnologies‘s full profile, request access.

Request a free trial

Tournay Biotechnologies Patents

Tournay Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2011519844-A Method for obtaining an extract of cranberry (cranberry) pomace that can be used in the prevention and treatment of conditions such as caries, gingivitis or sore throat in particular Pending 05-May-2008
EP-2285390-A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats Active 05-May-2008
US-20110059193-A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats Inactive 05-May-2008
WO-2009141524-A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats Inactive 05-May-2008
EP-2285390-B1 Method for obtaining an extract of cranberry pulp residues for use in the prevention and treatment of conditions such as caries, gingivitis or sore throats. Inactive 05-May-2008 A61K36/45
To view Tournay Biotechnologies’s complete patent history, request access »

Tournay Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tournay Biotechnologies FAQs

  • When was Tournay Biotechnologies founded?

    Tournay Biotechnologies was founded in 1992.

  • Where is Tournay Biotechnologies headquartered?

    Tournay Biotechnologies is headquartered in Lamothe Montravel, France.

  • What is the size of Tournay Biotechnologies?

    Tournay Biotechnologies has 14 total employees.

  • What industry is Tournay Biotechnologies in?

    Tournay Biotechnologies’s primary industry is Other Chemicals and Gases.

  • Is Tournay Biotechnologies a private or public company?

    Tournay Biotechnologies is a Private company.

  • What is Tournay Biotechnologies’s current revenue?

    The current revenue for Tournay Biotechnologies is .

  • When was Tournay Biotechnologies acquired?

    Tournay Biotechnologies was acquired on 10-Oct-2012.

  • Who acquired Tournay Biotechnologies?

    Tournay Biotechnologies was acquired by Nexira.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process